Post-Marketing Studies – Why Are They Becoming Increasingly Necessary and How Do You Conduct Them?

• By: ComplianceOnline Expert
• Date: March 16, 2012

There’s been an uptick in the number of post-approval Phase IV or post-marketing studies in the pharmaceutical industry. This is mainly due to a spike in rare adverse events following the release of a drug into the market and corresponding increase in the number of product recalls by manufacturers.

How do you conduct a successful post-marketing study? Read on to find out.